Biology Reference
In-Depth Information
Karray S, Juompan L, Maroun RC, Isenberg D, Silverman GJ, Zouali M. 1998. Structural basis
of the gp120 superantigen-binding site on human immunoglobulins. J Immunol 161: 6681±
6688.
Kelsoe G. 1996. Life and death in germinal centers (redux). Immunity 4: 107±111.
Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase
PL. 1994. Selective increase of activation antigens HLA-DR and CD38 on CD4
CD45RO
T
lymphocytes during HIV-1 infection. Clin Exp Immunol 95: 436±441.
Kimata H, Lindley I, Furusho K. 1995. Selective inhibition of spontaneous IgE and IgG4 produc-
tion by interleukin-8 in atopic patients. Blood 85: 3191±3198.
Kimata H, Yoshida A, Ishioka C, Fujimoto M, Lindley I, Furusho K. 1996. RANTES and mac-
rophage in¯ammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4
production by human B cells. J Exp Med 183: 2397±2402.
Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, Helm EB, Hoelzer D, Rossol R.
1997. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection
using cytoplasmic cytokine detection on single cell level by ¯ow cytometry. AIDS 11: 1111±
1118.
Koopman G, Wever PC, Ramkema MD, Bellot F, Reiss P, Keehnen RM, Ten Berge IJ, Pals ST.
1997. Expression of granzyme B by cytotoxic T lymphocytes in the lymph nodes of HIV-infected
patients. AIDS Res Hum Retroviruses 13: 227±233.
Kroese FG, Timens W, Nieuwenhuis P. 1990. Germinal center reaction and B lymphocytes: mor-
phology and function. Curr Top Pathol 84: 103±148.
Krzysiek R, Lefevre EA, Legendre C, Treton D, Dormont D, Galanaud P, Gras G, Richard Y.
1998. B cell-driven HIV type 1 expression in T cells: an essential role of CD86 costimulatory
molecule. AIDS Res Hum Retroviruses 14: 989±997.
Krzysiek R, Lefevre EA, Zou W, Foussat A, Bernard J, Portier A, Galanaud P, Richard Y. 1999.
Antigen receptor engagement selectively induces macrophage in¯ammatory protein-1 alpha
(MIP-1 alpha) and MIP-1 beta chemokine production in human B cells. J Immunol 162: 4455±
4463.
Krzysiek R, Lefevre EA, Bernard J, Foussat A, Galanaud P, Louache F, Richard Y. 2000. Regu-
lation of CCR6 chemokine receptor expression and responsiveness to M macrophage in¯am-
matory protein-3 alpha (MIP-3 alpha)/CCL20 in human B cells. Blood 96: 2338±2345.
Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N,
Glimcher LH. 1995. B7-1 and B7-2 costimulatory molecules activate di¨erentially the Th1/Th2
developmental pathways: application to autoimmune disease therapy. Cell 80: 707±718.
Kundu M, Sharma S, De Luca A, Giordano A, Rappaport J, Khalili K, Amini S. 1998. HIV-1 Tat
elongates the G1 phase and indirectly promotes HIV-1 gene expression in cells of glial origin. J
Biol Chem 273: 8130±8136.
Kundu RK, Sangiorgi F, Wu LY, Pattengale PK, Hinton DR, Gill PS, Maxson R. 1999. Expres-
sion of the human immunode®ciency virus-Tat gene in lymphoid tissues of transgenic mice is
associated with B-cell lymphoma. Blood 94: 275±282.
Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. 1996. HIV-1-Tat pro-
tein promotes chemotaxis and invasive behavior by monocytes. J Immunol 157: 974±977.
Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. 1983. Abnormalities of B-cell
activation and immunoregulation in patients with the acquired immunode®ciency syndrome. N
Engl J Med 309: 453±458.
Laurence J, Astrin SM. 1991. Human immunode®ciency virus induction of malignant transforma-
tion in human B lymphocytes. Proc Natl Acad Sci USA 88: 7635.
Lefevre EA, Krzysiek R, Loret EP, Galanaud P, Richard Y. 1999. Cutting edge: HIV-1 Tat protein
di¨erentially modulates the B cell response of naive, memory, and germinal center B cells. J
Immunol 163: 1119±1122.
